Loading...
Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy
Hyperprogressive disease (HPD) is a paradoxical phenomenon involving the acceleration of tumor progression after treatment with immune checkpoint inhibitors (ICIs). A 66-year-old male smoker with advanced lung adenocarcinoma started pembrolizumab for progressive disease following first-line chemothe...
Na minha lista:
| Udgivet i: | Intern Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Japanese Society of Internal Medicine
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6911749/ https://ncbi.nlm.nih.gov/pubmed/31327828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2892-19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|